Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 36 (RPL31P36)

Target
RPL31P36
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L31 pseudogene 36 (RPL31P36) is a human pseudogene representing a nonfunctional, genomic copy of the functional ribosomal protein L31 gene (RPL31). Pseudogenes such as RPL31P36 do not encode active proteins and generally do not have biological activity or relevance as drug or therapeutic targets[4][5][8]. They are typically the result of gene duplication or retrotransposition events and exist throughout the genome as genetic relics. This gene is specifically described as a pseudogene in every reference, meaning it does not produce a functional protein and is not considered a viable drug target or therapeutic target[4][5][8]. No disease associations, biological functions, interacting drugs, or biomarker roles have been ascribed to this pseudogene. Its aliases mainly reference database accessions or alternative names for the pseudogene; none are linked to a functional protein[4][5]. If you are seeking information about therapeutic ribosomal proteins, refer to the parent gene RPL31 ("Ribosomal protein L31"), not its pseudogene derivatives[1][3]. The presence of many pseudogenes like RPL31P36 is typical among ribosomal protein families[1][8]. Most such pseudogenes are not transcribed or translated into functional proteins and do not play direct roles in disease or drug action. In summary, RPL31P36 is a nonfunctional genomic sequence, not an active target or receptor, and should not be considered in therapeutic targeting or biomarker development.

Other names
RPL31_19_846RPL31P36

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 36 (RPL31P36).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 36 (RPL31P36).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call